Calithera Bio (CALA)

Calithera Bio (CALA) Stock Price & Analysis


CALA Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.04 - $13.38
Previous Close$0.05
Average Volume (3M)322.10K
Market Cap
Enterprise Value-$9.46M
Total Cash (Recent Filing)$34.07M
Total Debt (Recent Filing)$2.02M
Price to Earnings (P/E)>-0.1
May 11, 2023
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-25.58
Shares Outstanding4,865,257
10 Day Avg. Volume21,182
30 Day Avg. Volume322,096
Standard Deviation0.28
Financial Highlights & Ratios
Price to Book (P/B)0.05
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)14.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.18
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Calithera Bio’s price range in the past 12 months?
Calithera Bio lowest stock price was $0.04 and its highest was $13.38 in the past 12 months.
    What is Calithera Bio’s market cap?
    Currently, no data Available
    When is Calithera Bio’s upcoming earnings report date?
    Calithera Bio’s upcoming earnings report date is May 11, 2023 which is in 44 days.
      How were Calithera Bio’s earnings last quarter?
      Currently, no data Available
      Is Calithera Bio overvalued?
      According to Wall Street analysts Calithera Bio’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Calithera Bio pay dividends?
        Calithera Bio does not currently pay dividends.
        What is Calithera Bio’s EPS estimate?
        Calithera Bio’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Calithera Bio have?
        Calithera Bio has 4,865,257 shares outstanding.
          What happened to Calithera Bio’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Calithera Bio?
          Among the largest hedge funds holding Calithera Bio’s share is PRIMECAP Management Co. It holds Calithera Bio’s shares valued at 1M.


            Calithera Bio Stock Smart Score

            This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
            Learn more about TipRanks Smart Score

            Company Description

            Calithera Bio

            Calithera Biosciences, Inc. engages in discovering and developing small molecule drugs that that target novel and critical metabolic pathway in tumor and cance-fighting immune cells. It offers programs such as Pipeline, Glutaminase Inhibitor, and Arginase Inhibitor. The company was founded by James A. Wells and Susan M. Molineaux on March 9, 2010 and is headquartered in South San Francisco, CA.


            Forecast EPS vs Actual EPS

            Currently, no data available
            Please return soon. This page is being updated.

            Similar Stocks
            Price & Change
            Kintara Therapeutics
            QSAM Biosciences
            Ridgefield Acquisition

            Popular Stocks

            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis